NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood tests track lung cancer drug effectiveness
Disease control OngoingThis study is testing how well the drug brigatinib works for people with advanced non-small cell lung cancer that has a specific genetic change (ALK+). Researchers will also explore if simple blood tests (liquid biopsies) can help track how the cancer responds to treatment over t…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could personalize lung cancer care
Disease control OngoingThis study is testing if a simple blood test, taken at different times, can help doctors see how well a patient's advanced lung cancer is responding to an immunotherapy drug called pembrolizumab. Based on the blood test results, doctors will decide if the patient should continue …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Julia K. Rotow, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill targets 'Undruggable' lung cancer mutation in older and frail patients
Disease control OngoingThis trial is testing a pill called adagrasib for people with advanced lung cancer that has a specific genetic change called KRAS G12C. It focuses on patients who are 70 or older or who are in poorer health, groups often left out of other studies. The main goal is to see if the p…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Targeted radiation blasts spreading cancer cells in new trial
Disease control OngoingThis study is testing whether using a precise, high-dose radiation treatment on a few new or growing tumors can help people with advanced lung or breast cancer stay on their current medications longer. It aims to see if this approach can delay the cancer from getting worse. The t…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC